MERZOUKI ABDERRAZZAK (Chief Operating Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2018ACC: 0001128732-18-000013
DirectorOfficer· Chief Operating Officer
Since Aug 2018
+38M
Net shares
Net buyer
$38.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
38M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38M
Price / share
$0.00
Trade value
$38K
% of position
47.2%
8/27/2018
80.47M→118.47M
Total
Net shares
+38M
Net value
$38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/27/2018 | A · Award | +38M | $0.00 | $38K | 47.2% | 80.47M | 118.47M |
| Total | +38M | $38K | ||||||
Derivative Transactions0
No derivative transactions reported